[1] Ng SC, Shi HY, Hamidi N,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J].Lancet,2017,390(10114):2769-2778. [2] De Souza HSP1, Fiocchi C2, Iliopoulos D3. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy[J].Nat Rev Gastroenterol Hepatol,2017,14(12):739-749. [3] Ma X, Dai Z, Sun K, et al. Intestinal epithelial cell endoplasmic reticulum stress and inflammatory bowel disease pathogenesis: an update review[J].Front Immunol,2017,8:1271. [4] Koo JH, Lee HJ, Kim W, et al. Endoplasmic reticulum stress in hepatic stellate cells promotes liver fibrosis via PERK-mediated degradation of HNRNPA1 and up-regulation of SMAD2[J].Gastroenterology,2016,150(1):181-193. [5] Burman A, Tanjore H, Blackwell TS. Endoplasmic reticulum stress in pulmonary fibrosis[J].Matrix Biol,2018,68-69:355-365. [6] Ke B, Zhu N, Luo F, et al. Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis[J].Mol Med Rep,2017,16(2):1014-1020. [7] Fernández A, Ordóez R, Reiter RJ, et al. Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis[J].J Pineal Res,2015,59(3):292-307. [8] Cao SS. Epithelial ER stress in crohn's disease and ulcerative colitis[J].Inflamm Bowel Dis,2016,22(4):984-993. [9] Lawrance IC, Rogler G, Bamias G,et al. Cellular and molecular mediators of intestinal fibrosis[J].J Crohns Colitis,2017,11(12): 1491-1503. [10] Truffi M, Sorrentino L, Monieri M, et al. Inhibition of fibroblast activation protein restores a balanced extracellular matrix and reduces fibrosis in crohn's disease strictures ex vivo[J].Inflamm Bowel Dis,2018,24(2):332-345. [11] Loeuillard E. 2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling[J].World J Gastroenterol,2014,20(48):18207. [12] Rieder F, Lawrance IC, Leite A, et al. Predictors of fibrostenotic Crohn's disease[J].Inflamm Bowel Dis,2011,17(9):2000-2007. [13] Nijhuis A, Biancheri P, Lewis A, et al. In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts[J].Clin Sci (Lond),2014,127(5):341-350. [14] Yang J, Zhou CZ, Zhu R,et al. miR-200b-containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial-mesenchymal transition[J].J Gastroenterol Hepatol,2017,32(12):1966-1974. [15] Mehta SJ, Lewis A, Nijhuis A,et al. Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition[J].J Cell Mol Med,2018,22(11): 5617-5628. [16] Lewis A, Mehta S, Hanna LN,et al.Low serum levels of microRNA-19 are associated with a stricturing Crohn's disease phenotype[J].Inflamm Bowel Dis,2015,21:1926-1934. [17] Lenna S, Trojanowska M. The role of endoplasmic reticulum stress and the unfolded protein response in fibrosis[J].Curr Opin Rheumatol,2012,24(6):663-668. [18] Flier SN, Tanjore H, Kokkotou EG, et al. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis[J].J Biol Chem,2010,285(26):20202-20212. [19] Scharl M, Huber N, Lang S, et al. Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis[J].Clin Transl Med,2015,4:1. [20] Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition[J].Nat Rev Mol Cell Biol,2014,15(3):178-196. [21] Tanjore H, Cheng DS, Degryse A L, et al. Alveolar epithelial cells undergo epithelial-to-mesenchymal transition in response to endoplasmic reticulum stress[J].J Biol Chem,2015,290(6):3277. [22] 吕腾飞. 菌群紊乱导致的内质网应激在炎症性肠病肠壁纤维化中的作用[D].南京大学,2016. [23] De Minicis S, Candelaresi C, Agostinelli L, et al. Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution[J].Liver Int,2012,32(10):1574-1584.
2019, Vol. 36 
